- Collaboration. At Mayo Clinic, urologists, oncologists, radiation oncologists, pathologists and radiologists work as a multidisciplinary team to provide whole-person care for those with bladder cancer.
- Expertise. Mayo Clinic is a leader in bladder cancer diagnosis and treatment, including urological research, surgical procedures and other treatments. Mayo Clinic surgeons pioneered many of the procedures used to treat bladder cancer today. Your care team is prepared with the knowledge and resources to provide you with exactly the care you need.
- Experience. Mayo Clinic doctors have extensive experience caring for people with bladder cancer. Each year, more than 3,000 people with bladder cancer seek care at Mayo Clinic.
- Access to the latest in bladder cancer treatment. Mayo Clinic makes extensive use of the newest technology to improve chances for positive outcomes. Some people may benefit from robotic surgery, an alternative to both conventional open surgery and traditional laparoscopy. If invasive cancer requires bladder removal (radical cystectomy), a surgical procedure to construct a new bladder (neobladder reconstruction) inside the abdomen is an option for many people.
- A full range of treatment options to consider. Mayo Clinic doctors will work with you to review all of your treatment options and choose the treatment that best suits your needs and goals. The range of treatments offered to people with bladder cancer includes surgery, chemotherapy, biological therapy and radiation therapy.
- Comprehensive cancer center. Mayo Clinic Cancer Center meets strict standards for a National Cancer Institute comprehensive cancer center, which recognizes scientific excellence and a multidisciplinary approach to cancer prevention, diagnosis and treatment.
Mayo Clinic in Rochester, Minn., Mayo Clinic in Jacksonville, Fla., and Mayo Clinic in Scottsdale, Ariz., are ranked among the Best Hospitals for cancer by U.S. News & World Report.
June 30, 2015
- What you need to know about bladder cancer. National Cancer Institute. http://www.cancer.gov/publications/patient-education/wyntk-bladder-cancer. Accessed May 4, 2015.
- Bladder cancer treatment (PDQ). National Cancer Institute. http://www.cancer.gov/cancertopics/pdq/treatment/bladder/healthprofessional. Accessed May 4, 2015.
- Niederhuber JE, et al., eds. Bladder cancer. In: Abeloff's Clinical Oncology. 5th ed. Philadelphia, Pa.: Churchill Livingstone Elsevier; 2014. http://www.clinicalkey.com. Accessed May 4, 2015.
- Bladder and other urothelial cancers screening (PDQ). National Cancer Institute. http://www.cancer.gov/cancertopics/pdq/screening/bladder/healthprofessional. Accessed May 4, 2015.
- Bladder cancer. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed May 4, 2015.
- Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1 and Tis): 2007 update. Linthicum, Md.: American Urological Association. http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines.cfm?sub=bc. Accessed May 4, 2015.
- Wein AJ, et al., eds. Urothelial cancer. In: Campbell-Walsh Urology. 10th ed. Philadelphia, Pa.: Saunders Elsevier; 2012. http://www.clinicalkey.com. Accessed May 4, 2015.
- FDA drug safety communication: Update to ongoing safety review of Actos (pioglitazone) and increased risk of bladder cancer. U.S. Food and Drug Administration. http://www.fda.gov/Drugs/DrugSafety/ucm259150.htm. Accessed May 5, 2015.
- Knoedler J, et al. Organ-sparing surgery in urology: Partial cystectomy. Current Opinion Urology. 2015;25:111.
- Smith ND, et al. The RAZOR (randomized open vs. robotic cystectomy) trial: Study design and trial update. British Journal of Urology International. 2015;115:198.
- Cook AJ. Decision Support System. Mayo Clinic, Rochester, Minn. Dec. 17, 2014.
- Castle EP (expert opinion). Mayo Clinic, Phoenix/Scottsdale, Ariz. June 11, 2015.